These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 12392036)
21. Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice. Chalmers JD; Tebboth A; Gayle A; Ternouth A; Ramscar N NPJ Prim Care Respir Med; 2017 Jun; 27(1):43. PubMed ID: 28663549 [TBL] [Abstract][Full Text] [Related]
22. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design. Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416 [TBL] [Abstract][Full Text] [Related]
23. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions. Anzueto A Am J Med; 2006 Oct; 119(10 Suppl 1):46-53. PubMed ID: 16996899 [TBL] [Abstract][Full Text] [Related]
24. Drugs in clinical development for chronic obstructive pulmonary disease. Molfino NA Respiration; 2005; 72(1):105-12. PubMed ID: 15753645 [TBL] [Abstract][Full Text] [Related]
25. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK. Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512 [TBL] [Abstract][Full Text] [Related]
26. Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD). Chalmers JD; Poole C; Webster S; Tebboth A; Dickinson S; Gayle A Respir Res; 2018 Apr; 19(1):63. PubMed ID: 29642882 [TBL] [Abstract][Full Text] [Related]
27. Guideline for the management of chronic obstructive pulmonary disease (COPD): 2004 revision. Bateman ED; Feldman C; O'Brien J; Plit M; Joubert JR; S Afr Med J; 2004 Jul; 94(7 Pt 2):559-75. PubMed ID: 15283307 [TBL] [Abstract][Full Text] [Related]
28. Medical management of chronic obstructive pulmonary disease. Sciurba FC Chest Surg Clin N Am; 2003 Nov; 13(4):615-29. PubMed ID: 14682598 [TBL] [Abstract][Full Text] [Related]
30. Impact and prevention of severe exacerbations of COPD: a review of the evidence. Halpin DM; Miravitlles M; Metzdorf N; Celli B Int J Chron Obstruct Pulmon Dis; 2017; 12():2891-2908. PubMed ID: 29062228 [TBL] [Abstract][Full Text] [Related]
32. What is in the guidelines about the pharmacological treatment of chronic obstructive pulmonary disease? López-Campos JL; Calero Acuña C Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):43-51. PubMed ID: 23551023 [TBL] [Abstract][Full Text] [Related]
33. Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial. Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Anzueto A; Alagappan VK; Siddiqui S; Rekeda L; Miller CJ; Zetterstrand S; Reisner C; Rennard SI Am J Respir Crit Care Med; 2016 Sep; 194(5):559-67. PubMed ID: 27585384 [TBL] [Abstract][Full Text] [Related]
34. The clinical and integrated management of COPD. Bettoncelli G; Blasi F; Brusasco V; Centanni S; Corrado A; De Benedetto F; De Michele F; Di Maria GU; Donner CF; Falcone F; Mereu C; Nardini S; Pasqua F; Polverino M; Rossi A; Sanguinetti CM Sarcoidosis Vasc Diffuse Lung Dis; 2014 May; 31 Suppl 1():3-21. PubMed ID: 24820963 [TBL] [Abstract][Full Text] [Related]
35. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)--why and what? Vestbo J; Hurd SS; Rodriguez-Roisin R Clin Respir J; 2012 Oct; 6(4):208-14. PubMed ID: 22906068 [TBL] [Abstract][Full Text] [Related]
36. The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study. Hsieh MJ; Huang SY; Yang TM; Tao CW; Cheng SL; Lee CH; Kuo PH; Wu YK; Chen NH; Hsu WH; Hsu JY; Lin MS; Wang CC; Wei YF; Tsai YH Int J Chron Obstruct Pulmon Dis; 2018; 13():2949-2959. PubMed ID: 30310271 [TBL] [Abstract][Full Text] [Related]
37. Precision health: treating the individual patient with chronic obstructive pulmonary disease. Obeidat M; Sadatsafavi M; Sin DD Med J Aust; 2019 May; 210(9):424-428. PubMed ID: 30977152 [TBL] [Abstract][Full Text] [Related]
39. Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations. Calverley PM; Postma DS; Anzueto AR; Make BJ; Eriksson G; Peterson S; Jenkins CR Int J Chron Obstruct Pulmon Dis; 2016; 11():381-90. PubMed ID: 26952309 [TBL] [Abstract][Full Text] [Related]
40. Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly : an appraisal of published evidence. Kunisaki KM; Rice KL; Niewoehner DE Drugs Aging; 2007; 24(4):303-24. PubMed ID: 17432925 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]